Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Mirati Therapeutics (MRTX)

28.7 0.35 (1.23%)

02-23 16:00

Open:

28.6

Pre. Close:

28.35

High:

28.775

Low:

27.2

Volume:

320,888

Market Cap:

801M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

28.777 - 28.887

28.887 - 29.015

Low:

26.908 - 27.023

27.023 - 27.156

Close:

28.476 - 28.669

28.669 - 28.891

Technical analysis  (as of: 2018-02-23 4:41:43 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 35.62     One year: 41.61

Support:

Support1: 26.92    Support2: 24.70

Resistance:

Resistance1: 30.50    Resistance2: 35.62

Pivot:

28.16

Moving Averages:

MA(5): 28.36     MA(20): 27.66

MA(100): 19.21     MA(250): 10.62

MACD:

MACD(12,26): 1.34     Signal(12,26,9): 1.61

%K %D:

%K(14,3): 59.20     %D(3): 58.14

RSI:

RSI(14): 59.37

52-Week:

High: 30.5  Low: 2.7  Change(%): 382.4

Average Vol(K):

3-Month: 44274  10-Days 37207

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
MRTX has closed below upper band by 37.8%. Bollinger Bands are 19.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 15 Nov 2017 19:18:45 GMT
Mirati Therapeutics: Buy The Dip

Mon, 18 Sep 2017 15:22:30 GMT
Mirati Therapeutics: Double Could Be Just The Beginning

Mon, 31 Jul 2017 16:41:15 GMT
Mirati Therapeutics: Is This $5 Busted IPO A Buy, Sell, Or Hold?

Fri, 15 Sep 2017 12:22:30 GMT
Mirati Therapeutics' stock soars on heavy volume after positive cancer ...

Mon, 13 Nov 2017 21:11:15 GMT
Mirati Therapeutics Announces Advancement Of First-In-Class Opportunities With ...

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  0

Industry:  0

Shares Out. (M)

25.30

Shares Float (M)

25.20

% Held by Insiders

% Held by Institutions

68.40

Shares Short (K)

1693

Shares Short Prior Month (K)

876

Stock Financials

EPS

-3.110

EPS Est. Current Year

-3.200

EPS Est. Next Year

-2.770

EPS Est. Next Quarter

-0.850

Forward EPS

-2.360

Book Value (p.s.)

10.990

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-87.7

Return on Equity (ttm)

-105.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.884

Qtrly Earnings Growth

Operating Cash Flow (M)

-67.06

Levered Free Cash Flow (M)

-38.27

atoplab.com

Valuation

P/E

-9.23

P/E Growth Ratio

0.01

P/BV

2.61

P/S

P/CF

-10.83

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.